Dong J, Tong W, Liu M, Liu M, Liu J, Jin X
Transl Neurodegener. 2024; 13(1):66.
PMID: 39716330
PMC: 11667944.
DOI: 10.1186/s40035-024-00460-7.
Rao N, DeGulis O, Nomura T, Lee S, Hark T, Dynes J
bioRxiv. 2024; .
PMID: 39554163
PMC: 11565754.
DOI: 10.1101/2024.10.28.620698.
Wang J, Fourriere L, Gleeson P
Biochem J. 2024; 481(19):1297-1325.
PMID: 39302110
PMC: 11555708.
DOI: 10.1042/BCJ20240056.
Harracksingh A, Singh A, Mayorova T, Bejoy B, Hornbeck J, Elkhatib W
Sci Rep. 2024; 14(1):21615.
PMID: 39284887
PMC: 11405698.
DOI: 10.1038/s41598-024-70652-8.
Zhang J, Jiang Y, Dong X, Meng Z, Ji L, Kang Y
Alzheimers Res Ther. 2024; 16(1):160.
PMID: 39030577
PMC: 11264788.
DOI: 10.1186/s13195-024-01527-3.
A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer's disease.
Jaye S, Sandau U, McFarland T, Woltjer R, Saugstad J
Front Neurosci. 2024; 18():1426180.
PMID: 38915309
PMC: 11195150.
DOI: 10.3389/fnins.2024.1426180.
Long term rescue of Alzheimer's deficits by one-time gene-editing of C-terminus.
Aulston B, Gimse K, Bazick H, Kramar E, Pizzo D, Parra-Rivas L
bioRxiv. 2024; .
PMID: 38895278
PMC: 11185791.
DOI: 10.1101/2024.06.08.598099.
Small GTPases control macropinocytosis of amyloid precursor protein and cleavage to amyloid-β.
Chiu J, Krupa J, Seah C, Pasternak S
Heliyon. 2024; 10(10):e31077.
PMID: 38799759
PMC: 11126852.
DOI: 10.1016/j.heliyon.2024.e31077.
Clathrin mediated endocytosis in Alzheimer's disease: cell type specific involvement in amyloid beta pathology.
Jaye S, Sandau U, Saugstad J
Front Aging Neurosci. 2024; 16():1378576.
PMID: 38694257
PMC: 11061891.
DOI: 10.3389/fnagi.2024.1378576.
A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
Acharya N, Grossman H, Clifford P, Levin E, Light K, Choi H
J Alzheimers Dis. 2024; 98(1):163-186.
PMID: 38393907
PMC: 10977376.
DOI: 10.3233/JAD-231028.
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change.
Malik N, Miah M, Galgani A, McAleese K, Walker L, LeBeau F
Acta Neuropathol. 2024; 147(1):40.
PMID: 38353753
PMC: 10866780.
DOI: 10.1007/s00401-024-02691-4.
Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.
Kumar A, Nader M, Deep G
Pharmacol Rev. 2024; 76(2):199-227.
PMID: 38351075
PMC: 10877757.
DOI: 10.1124/pharmrev.122.000788.
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach.
Haut F, Argyrousi E, Arancio O
Int J Mol Sci. 2024; 25(1).
PMID: 38203429
PMC: 10779219.
DOI: 10.3390/ijms25010259.
Negative Regulation of Cathepsins by β-Amyloid.
Lundin B, Comby A, Berezovska O, Maesako M
eNeuro. 2024; 11(1).
PMID: 38199815
PMC: 10849021.
DOI: 10.1523/ENEURO.0258-23.2023.
BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
Kaur I, Behl T, Sundararajan G, Panneerselvam P, Vijayakumar A, Senthilkumar G
Neurotox Res. 2023; 41(6):698-707.
PMID: 37847429
DOI: 10.1007/s12640-023-00670-3.
Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
Kobro-Flatmoen A, Hormann T, Gouras G
J Alzheimers Dis. 2023; 95(2):719-733.
PMID: 37574734
PMC: 10578257.
DOI: 10.3233/JAD-230349.
APP family member dimeric complexes are formed predominantly in synaptic compartments.
Schilling S, August A, Meleux M, Conradt C, Tremmel L, Teigler S
Cell Biosci. 2023; 13(1):141.
PMID: 37533067
PMC: 10398996.
DOI: 10.1186/s13578-023-01092-6.
Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer's disease-transgenic mice.
Garcia M, Paulus A, Vazquez-Reyes S, Klementieva O, Gouras G, Bachiller S
Brain Behav Immun Health. 2023; 32:100663.
PMID: 37503358
PMC: 10369403.
DOI: 10.1016/j.bbih.2023.100663.
Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Schilling S, Pradhan A, Heesch A, Helbig A, Blennow K, Koch C
Acta Neuropathol Commun. 2023; 11(1):87.
PMID: 37259128
PMC: 10234039.
DOI: 10.1186/s40478-023-01577-y.
Emerging Nanotechnology for the Treatment of Alzheimer's Disease.
Singh A, Ansari V, Mahmood T, Ahsan F, Wasim R, Maheshwari S
CNS Neurol Disord Drug Targets. 2023; 23(6):687-696.
PMID: 37138478
DOI: 10.2174/1871527322666230501232815.